Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Cboe UK GBp

The Biotech Growth Trust PLC (BIOGL.XC)

734.00
-7.00
(-0.94%)
As of 9:24:12 AM GMT+1. Market Open.

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
NameTitlePayExercisedYear Born
Mr. Samuel David Isaly Portfolio Manager -- -- 1945

The Biotech Growth Trust PLC

601 Lexington Avenue
54th Floor
New York, NY 10022
United States
212-739-6400 https://www.biotechgt.com/index.php/biog/home/overview/
Industry: 
Asset Management

Description

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.

Corporate Governance

The Biotech Growth Trust PLC’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

June 3, 2025 at 10:59 AM UTC - June 9, 2025 at 12:00 PM UTC

The Biotech Growth Trust PLC Earnings Date

Recent Events